FOOTHILL RANCH, Calif., April 20, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products, announced ...
The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance to Biolase and EdgeEndo's laser-assisted microfluidic irrigation device for disinfecting root canals. Built upon Biolase's ...
BIOLASE Inc (NASDAQ: BIOL) and EdgeEndo have announced the co-development of EdgePRO, a next-generation Laser-Assisted Microfluidic Irrigation device for endodontists. This new Microfluidic Irrigation ...
Biolase and EdgeEndo announced on April 21 at the American Association of Endodontists annual meeting that they will develop a laser-assisted microfluidic irrigation device.